Benchmark Holdings PLC & IGAS Energy PLC Are Surging Today… Should You Buy Either?

Benchmark Holdings PLC (LON:BMK) is a better investment than IGAS Energy PLC (LON:IGAS), argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s just like playing roulette in Vegas with certain stocks. There has not been any official release over the last few days on IGas Energy (LSE: IGAS) and Benchmark Holdings (LSE: BMK), yet their shares were up over 10% in early trade today. Both gave up up some of their gains before midday, but the pressing question for me is whether they still represent good value for money right now. 

Here’s my quick take. 

Benchmark Trades High — Too High? 

The shares of Benchmark are gaining strength after a poor performance earlier this year, when its stock plunged 30% on the back of disappointing sales figures for Salmosan Vet, a flagship sea lice treatment that is off-patent. 

Benchmark is an health science business that has star investor Neil Woodford on its shareholder register: it is a more obvious investment than IGas based on the sector’s trends, growth rates, financing needs and a few other elements. 

Reports over the weekend suggested that the group — which is growing by acquiring assets, most recently in the aquaculture genetics and breeding sector — is well positioned to launch new products, but in spite of that it remains unlikely to be profitable for some time. 

Benchmark is pioneering vaccines for animals as an alternative and the group is also at the forefront of biotechnology in the animal sector,” Thisismoney.co.uk reported on Saturday. 

One of its most advanced products is HypoCat, designed to treat human allergic reactions to cats by vaccinating cats rather than the people affected by them.” 

Its stock has been on a roll since 27 July, when it announced a couple of bolt-on, cash-funded acquisitions for £11m. It traded at 62p before then, which yields a 40% performance in less than three weeks, and means that the market is now convinced that its strategy could pay off. 

I’d certainly keep an eye on it with the idea of investing part of my savings in its shares sooner rather than later. Consider that at its current price of 88p a share, its valuation is only about 15p above IPO — which was priced in December 2013 — and well below its 52-week high of 125p, but it is almost prohibitive based on revenues and cash flow multiples. That said, if you’re happy to embrace risk by betting on its healthy pipeline of products, you should snap up its stock right now. 

It is A Balancing Act For IGas Energy

IGas stock is rising from a very low level — in spite of today’s performance, it is still down 70% over the last 12 months!

Management has the backing of the UK government, but fracking doesn’t have the backing of local communities. This might not be an insurmountable hurdle over the very long term, but it renders IGas Energy’s mission particularly difficult and comes on top of obvious financial constraints, given that its balance sheet carries a significant debt load. 

The government continues in its attempts to break down the barriers to allow companies to frack in the UK after the Minister of State for Energy and Climate Change Andrea Leadsom visited IGas Energy’s proposed site in Warrington, Cheshire, on Thursday,” Alliance News reported on Friday. 

Operationally, IGas is faced with obvious regulatory risks. Consider that Cuadrilla Resources, a rather small shale gas company based in Staffordshire, recently said that it planned to appeal against the Lancashire County Council’s decision to reject two of its planning permits. Why?

Hydraulic fracking isn’t loved very much by the locals as it brings “noise and visual impacts“, and here is where the investment in IGas and any other rivals becomes particularly risky. 

In fact, although it’s possible that IGas may find a way to get around most of these issues over time, it’s also very likely that many of its projects will have to face significant delays, which renders vain any attempt to model its cash flows accurately. This is also a threat to its business model. 

Elsewhere, its partnership with Switzerland’s Ineos is one element I like, but its financials are stretched, which signals dilution risk.

So, personally I’d avoid this highly speculative trade, whose value is down 30% since the turn of the year.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is 2026 the year the Diageo share price bounces back?

Will next year be the start of a turnaround for the Diageo share price? Stephen Wright looks at a key…

Read more »

Investing Articles

Here’s my top FTSE 250 pick for 2026

UK investors looking for under-the-radar opportunities should check out the FTSE 250. And 2026 could be an exciting year for…

Read more »

Yellow number one sitting on blue background
Investing Articles

Here’s my number 1 passive income stock for 2026

Stephen Wright thinks a 5.5% dividend yield from a company with a strong competitive advantage is something passive income investors…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Should I sell my Scottish Mortgage shares in 2026?

After a strong run for Scottish Mortgage shares, our writer wonders if he should offload them to bank profits in…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Down 35%! These 2 blue-chips are 2025’s big losers. But are they the best shares to buy in 2026?

Harvey Jones reckons he's found two of the best shares to buy for the year ahead, but he also acknowledges…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

State Pension worries? 3 investment trusts to target a £2.6m retirement fund

Royston Wild isn't worried about possible State Pension changes. Here he identifies three investment trusts to target a multi-million-pound portfolio.

Read more »

Smiling white woman holding iPhone with Airpods in ear
Dividend Shares

4 dirt-cheap dividend stocks to consider for 2026!

Discover four great dividend stocks that could deliver long-term passive income -- and why our writer Royston Wild thinks they’re…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

These fabulous 5 UK stocks doubled in 2025 – can they do it again next year?

These five UK stocks have more than doubled investors' money as the FTSE 100 surges. Harvey Jones wonders if they…

Read more »